ALDURAZYME® (laronidase) is indicated for adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms.
Limitations of Use:
Sanofi Genzyme offers dedicated support for patients and families affected by rare disease.
The Program helps eligible individuals in the United States who are prescribed treatment with Aldurazyme
Warnings and Precautions
Anaphylaxis and Hypersensitivity Reactions
Acute Respiratory Complications Associated with Administration
Risk of Acute Cardiorespiratory Failure
Patients 6 years of age and older
Patients 6 months of age and older
Please see Full Prescribing Information including Boxed WARNING for Aldurazyme.